FirstClub Raises $55 million Series B
FirstClub is a Biotech & Therapeutics company tied to Biotech & Therapeutics buyers are tracking this financing as a fresh capital-allocation signal.. Its latest Series B is $55M, with Mn. FirstClub, a Bengaluru as the listed market footprint.
What it does
Ramp has surpassed $1 billion in annualized revenue and generates positive free cash flow, with total payment volume soaring 170% year-over-year as of March 2026 Ramp, the corporate spend management platform, announced it has raised a huge $750 million Series F funding round, valuing the company at an incredible $44 billion.
Traction
Peak XV Partners, Sofina, boosting its valuation, Accel and others backed the $55M Series B. Peak XV Partners backed the $55M Series B.
Trend impact
First-order signal: Peak XV Partners's backing of FirstClub's $55M Series B is a specific read on ramp has surpassed $1 billion in annualized revenue and generates positive free cash flow, with total payment volume, with the article evidence pointing to peak xv partners backed the $55m series b.. Investor-economist thesis: the bull case follows healthcare execution where clinical evidence, distribution, and regulatory timing drive outcomes; it helps buyers and vendors that can turn FirstClub's wedge into measurable adoption, pricing power, risk reduction, or throughput gains, while it pressures single-asset or services-heavy healthcare models that cannot show evidence quality or distribution. The bear-case reversal is execution proof: if FirstClub cannot convert the new capital into repeat usage, customer expansion, margin lift, or externally verifiable outcomes, the round reads as financing momentum rather than durable market leadership. Watch clinical or provider milestones, reimbursement or regulatory progress, patient/provider adoption, follow-on capital quality.
Funding history
- June 4, 2026 · Series B · $55 million · Peak XV Partners
- June 4, 2026 · Pre-Seed · an undisclosed amount · Peak XV
- June 4, 2026 · Series B · an undisclosed amount · undisclosed investors